These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Protective effects of ME3221 on hypertensive complications and lifespan in salt-loaded stroke-prone spontaneously hypertensive rats. Nagura J, Yamamoto M, Hui C, Yasuda S, Hachisu M, Konno F. Clin Exp Pharmacol Physiol; 1996 Mar; 23(3):229-35. PubMed ID: 8934613 [Abstract] [Full Text] [Related]
8. Angiotensinogen depletion by high renin levels in hypertensive rats: no evidence for tonic stimulation of angiotensinogen by angiotensin II. Gahnem F, Camargo MJ, von Lutterotti N, Laragh JH, Sealey JE. J Hypertens; 1995 Jan; 13(1):91-6. PubMed ID: 7759857 [Abstract] [Full Text] [Related]
9. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review. Dahlöf B. J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480 [Abstract] [Full Text] [Related]
10. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 2nd communication: valsartan prevents end-organ damage in spontaneously hypertensive stroke-prone rats during 1-year treatment. Kometani M, Hayashi N, Yamamoto S, Nakao K, Inukai T. Arzneimittelforschung; 1997 May; 47(5):613-9. PubMed ID: 9205774 [Abstract] [Full Text] [Related]
11. The future role of losartan. Hansson L. J Hum Hypertens; 1995 Nov; 9 Suppl 5():S55-8. PubMed ID: 8583483 [Abstract] [Full Text] [Related]
14. Control of blood pressure and end-organ damage in maturing salt-loaded stroke-prone spontaneously hypertensive rats by oral angiotensin II receptor blockade. Camargo MJ, von Lutterotti N, Campbell WG, Pecker MS, James GD, Timmermans PB, Laragh JH. J Hypertens; 1993 Jan; 11(1):31-40. PubMed ID: 8382237 [Abstract] [Full Text] [Related]
15. Losartan reduces albuminuria in patients with essential hypertension. An enalapril controlled 3 months study. Nielsen S, Dollerup J, Nielsen B, Jensen HA, Mogensen CE. Nephrol Dial Transplant; 1997 Jan; 12 Suppl 2():19-23. PubMed ID: 9269694 [Abstract] [Full Text] [Related]
16. ME3221, a surmountable angiotensin AT1-receptor antagonist, prevents hypertensive complications in aged stroke-prone spontaneously hypertensive rats. Nagura J, Hui C, Yamamoto M, Yasuda S, Abe M, Hachisu M, Konno F. Jpn J Pharmacol; 1996 May; 71(1):39-49. PubMed ID: 8791170 [Abstract] [Full Text] [Related]
17. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension. Bauer IH, Reams GP, Wu Z, Lau-Sieckman A. J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905 [Abstract] [Full Text] [Related]
18. A new class of therapeutic agents: the angiotensin II receptor antagonists. Timmermans PB, Smith RD. Cardiologia; 1994 Dec; 39(12 Suppl 1):397-400. PubMed ID: 7634303 [Abstract] [Full Text] [Related]
19. [Losartan, an angiotensin II receptor blocker: a new trend in cardiovascular chemotherapy]. Krasnikova TL. Klin Med (Mosk); 1996 Dec; 74(3):17-21. PubMed ID: 8926692 [No Abstract] [Full Text] [Related]
20. Alterations in vascular structure and function after short-term losartan treatment in spontaneously hypertensive rats. Soltis EE. J Pharmacol Exp Ther; 1993 Aug; 266(2):642-6. PubMed ID: 8355197 [Abstract] [Full Text] [Related] Page: [Next] [New Search]